-
Heroin vaccine could tackle opioid addiction
europeanpharmaceuticalreview
April 30, 2019
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
-
Report calls into question effectiveness of pyridoxine-doxylamine
europeanpharmaceuticalreview
April 30, 2019
Report calls into question effectiveness of pyridoxine-doxylamine.
-
Legal ruling confirms that ‘routine’ discoveries can be patented
europeanpharmaceuticalreview
April 30, 2019
Legal ruling confirms that ‘routine’ discoveries can be patented.
-
Fosmidomycin-piperaquine combination provides promising malaria treatment
europeanpharmaceuticalreview
April 29, 2019
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication…
-
Bio-Techne, Elpiscience Enter Strategic Anti-Cancer Alliance
b3cnewswire
April 23, 2019
Elpiscience will have access to multiple antibodies from Bio-Techne's product portfolio for use in the development of biopharmaceuticals...
-
TFS International to Strengthen Strategic Planning Capabilities with Citeline Deal
b3cnewswire
April 23, 2019
TFS International, a leading, mid-sized clinical Contract Research Organization (CRO) is dedicated to the innovative use of technology to advance clinical development.
-
Stem cells to grow new immune system in Crohn’s disease patients
europeanpharmaceuticalreview
April 22, 2019
A phase III clinical trial looks to use a patients own stem cells to treat the debilitating disease…
-
Prostate cancer treatment reduced from 37 treatments to 5
europeanpharmaceuticalreview
April 22, 2019
A minimally invasive hydrogel technology was administered, and has previously shown to decrease treatment side effects…
-
Why are BACE inhibitors failing clinical trials?
europeanpharmaceuticalreview
April 19, 2019
Researchers are now looking to identify if BACE1 is involved in adult hippocampal neurogenesis, and responsible for the brains ability to repair itself…
-
Bacterial therapy shows early promise in patients with advanced solid tumours
europeanpharmaceuticalreview
April 19, 2019
Researchers have presented results of a Phase I clinical trial using bacterial Clostridium novyi-NT spores to target advanced solid tumours…